Fuad El-Hibri, chairman and chief executive officer at Emergent BioSolutions Inc., is a finalist for the Ernst & Young Entrepreneur of the Year® 2009 Award in the Greater Washington region. The awards program recognizes extraordinary innovation, financial performance and personal commitment to a businesses and its community. Emergent BioSolutions, based in Rockville, is a biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics.
skip to main |
skip to sidebar
Fuad El-Hibri Biography
Labels
- Abdul Aziz Said (1)
- academic (1)
- Activism and Peace Work (1)
- Aeras Global TB Foundation (1)
- American Society of Hematology (2)
- Anthrax (3)
- anthrax vaccine (1)
- Anthrax vaccines (16)
- Arab world (1)
- Atlanta (1)
- award (3)
- B-cell chronic lymphocytic leukemia (1)
- BARDA (1)
- Bendamustine (1)
- biopharmaceutical (1)
- biopharmaceutical company (1)
- Biosolutions (1)
- BioSolutions Inc (1)
- Biotech (1)
- Biotech CEO of the Year (1)
- Biotechnology (1)
- Biotechnology and Pharmaceuticals (1)
- Biothrax (7)
- BIOTHRAX® (2)
- Board of directors (2)
- Business (13)
- Business Power 500 (1)
- businessman (1)
- Businessweek (1)
- california (1)
- Centers for Disease Control and Prevention (1)
- CEO (1)
- Chairman (5)
- Chief Executive Officer (25)
- Chief Exeutive Officer (3)
- Chief financial officer (2)
- Chief operating officer (1)
- Clinical trial (5)
- colleagues (1)
- Colman McCarthy (1)
- Common stock (1)
- Conference call (2)
- Corporation (1)
- Crisis (1)
- Daniel Heifetz (1)
- DEPARTMENT OF HEALTH AND HUMAN SERVICES (1)
- Dr. Mary Elizabeth King (1)
- El Hibri Charitable Foundation (1)
- el-hibri (1)
- El-Hibri Peace Education Prize (4)
- emergent Bioslutions (1)
- Emergent BioSolutions (50)
- Emergent Biosolutions Inc (3)
- Employment (1)
- entrepreneur (3)
- Ernst Young (1)
- European Parliament (1)
- Executive (2)
- finance (1)
- Financial Results (1)
- Food and Drug Administration (13)
- fuad (6)
- fuad el-hibri (44)
- Gene Sharp (1)
- Global Healthcare Conference (1)
- Harvard University (1)
- Health (2)
- Health care (1)
- Healthcare Conference (2)
- Heifetz International Music Institute (1)
- Hematology (1)
- Honors (1)
- Hosni Mubarak (1)
- http://projects.washingtonpost.com/post200/2007/executive/3921/ (1)
- Hudson Institute (1)
- Human rights (1)
- Humanitarian aid (3)
- Inc. (1)
- Infectious disease (7)
- International Biomedical Research Alliance (1)
- International Traffic in Arms Regulations (1)
- Investor relations (2)
- Investors (3)
- Jascha Brodsky (1)
- Kennedy (1)
- Kofi Annan (1)
- Leadership (2)
- Lebanese (3)
- Lebanon (1)
- Leukemia (1)
- Leukemia and Lymphoma Society (1)
- Life Sciences Conference (1)
- Lymphocyte (1)
- Lymphoma (1)
- Management (1)
- Martin O'Malley (1)
- Maryland (3)
- Medical research (1)
- Middle East (2)
- muslims (1)
- Nancy Ajram (1)
- National Cancer Institute (1)
- National Health Museum (1)
- National Institute of Allergy and Infectious Diseases (2)
- National Institutes of Health (2)
- NATO (2)
- Needham and Company Healthcare Conference (1)
- New York Stock Exchange (2)
- Nobel Peace Prize (1)
- Non-Hodgkin lymphoma (2)
- Non-profit organization (2)
- North Atlantic Treaty Organization (1)
- peace (2)
- Pharmaceuticals (1)
- Philanthropy (1)
- Profile (2)
- profiles fuad (3)
- Public health (2)
- Research and development (3)
- Research Scholars (1)
- Rockville (2)
- Rockville Maryland (3)
- S.C. Johnson Graduate School of Management (1)
- Santa Cruz (1)
- Scholars Program (1)
- Seattle (2)
- Singapore Ministry of Health (1)
- Social Network (2)
- Society and Culture (1)
- South Africa (1)
- South African Tuberculosis Vaccine (1)
- Stanford University (2)
- Stock (1)
- Strategic National Stockpile (2)
- Subsidiary (1)
- Systemic Lupus Erythematosus (1)
- Takreem Achievement Awards (1)
- TB (1)
- TB Vaccine (1)
- Tech Council of Maryland (1)
- Technology (1)
- Trubion Pharmaceuticals (2)
- Tuberculosis (3)
- Tuberculosis Consortium Vaccinates. (1)
- U.S. Food and Drug Administration (4)
- U.S. government (3)
- United States (12)
- United States Chamber of Commerce (1)
- United States Department of Defense (1)
- United States Department of Health and Human Services (2)
- United States. (1)
- University of Oxford (2)
- US government (2)
- Vaccination (1)
- Vaccine (1)
- Venture capital (1)
- Vice President (1)
- vilcek (1)
- vileck foundation (1)
- Wael Ghonim (1)
- Washington (1)
- Washington D.C (2)
- Washington Post (1)
- Webcast (3)
- Website (1)
- World Health Organization (1)
- Yale (1)
- Yale university (3)
Followers
Blog Archive
-
▼
2009
(22)
-
▼
August
(16)
- Emergent BioSolutions Inc., Q2 2009 Earnings Call ...
- Emergent BioSolutions Inc. (EBS) CEO & Chairman, 1...
- EMERGENT BIOSOLUTIONS INC Profile
- Fuad El-Hibibri on Business Week
- Fuad El-Hibri on Corridor Inc.
- Fuad El-Hibri on Ttiqq
- 2007 Executive Compensation Report
- Emergent Biosolutions’ Typhoid Vaccine Candidate A...
- Emergent looks to buy Maryland lab
- EMERGENT BIOSOLUTIONS ANNOUNCES RESULTS FROM ANNUA...
- Fuad El-Hibri -Speaker Life Science Alliances Worl...
- Fuad El-Hibri Chief Executive Officer and Chairman...
- Local Fuad El-Hibri Named EY Entrepreneur of the Year
- Fuad El-Hibri on Backtype
- Fuad El-Hibri discusses challenges of marketing ov...
- Peace Prize awarded to Center for Nonviolence’s Ke...
-
▼
August
(16)
About Me
- Fuad El-Hibri
- Fuad El-Hibri, Chief Executive Officer and Chairman of the Board of Directors. Mr. El-Hibri has served as chief executive officer and chairman of the board of directors since June 2004 and as president from March 2006 to April 2007. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a result of our corporate reorganization, BioPort became a wholly owned subsidiary of Emergent.